Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma

Circular RNA has been revealed as a potential biomarker in multiple malignancies. However, few studies have focused on its potential to be prognostic markers in lung squamous cell carcinoma (LSCC). In this work, we aimed to build a prognostic model of resected LSCC based on circular RNA pyruvate deh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational lung cancer research 2019-12, Vol.8 (6), p.907-919
Hauptverfasser: Sun, Xiao, Wang, Maolong, Xu, Rongjian, Zhang, Dongyang, Liu, Ao, Wang, Yuanyong, Lu, Tong, Xin, Yanlu, Zhao, Yandong, Xuan, Yunpeng, Qiu, Tong, Wang, Hao, Li, Shicheng, Wo, Yang, Liu, Dahai, Zhao, Jinpeng, Fu, Bo, Lan, Yaliang, Han, Yudong, Jiao, Wenjie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Circular RNA has been revealed as a potential biomarker in multiple malignancies. However, few studies have focused on its potential to be prognostic markers in lung squamous cell carcinoma (LSCC). In this work, we aimed to build a prognostic model of resected LSCC based on circular RNA pyruvate dehydrogenase kinase 1 (circPDK1) and other clinicopathological factors. circPDK1 was identified via next-generation sequencing. Three hundred two cases of LSCC tissue and their adjacent normal lung tissues were obtained from multiple medical centers and divided into study cohort (n=232) and validation cohort (n=70). The expression of circPDK1 was detected for analyzing its potential prognostic value for recurrence-free survival (RFS) and overall survival (OS) in LSCC. Finally, combined with circPDK1, T staging, lymph nodes (LN) metastasis status, age, and serum squamous cell Carcinoma Antigen (SCCAg), we built a prognostic model by nomograms method and confirmed it in the validation cohort. CircPDK1 was identified to be overexpressed (P
ISSN:2218-6751
2226-4477
DOI:10.21037/tlcr.2019.11.20